Carolina Autotransfusion, Inc. (CATI) was founded in 1989 and has since become a leading provider of autotransfusion services. With a commitment to positive outcomes and optimum results, CATI offers hospitals and physicians the ability to limit patient exposure to blood products. The company is accredited by the American Academy of Blood Banks, a symbol of quality in the field. CATI is acclaimed for its ability to provide quality, reliable blood management services on short notice, catering to various hospital sizes and patient populations. CATI's mission to decrease patient exposure to allogeneic blood transfusions is evident in its dedication to providing perioperative blood management services that utilize the most current innovations and cutting-edge technology. The company promotes a comprehensive quality systems approach, encouraging continuous improvement and ensuring a high standard of care for patients and donors in all aspects of blood banking, transfusion, biotherapies, and relationship testing. With a focus on educating staff, physicians, and hospital personnel in effective research-proven techniques, CATI is dedicated to optimizing its standards of care by managing risk and intentionally focusing on quality. The company's dedication to quality, safety, and patient outcomes aligns with the internationally recognized AABB Accreditation program, further highlighting its commitment to providing quality products and services.
There is no investment information
No recent news or press coverage available for Carolina Autotransfusion, Inc..